author-photo

Haoyu Fu

Chinese Academy of Sciences

34

Papers

991

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Fluorinated graphene nanoribbons from unzipped single-walled carbon nanotubes for ultrahigh energy density lithium-fluorinated carbon batteries

2021 Science China. Materials
Show All
- Source
- Cite
- Save
Citations (3)
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells.

2021 Thoracic Cancer
Show All
- Source
- Cite
- Save
Citations (1)
The role of procalcitonin in differential diagnosis between acute radiation pneumonitis and bacterial pneumonia in lung cancer patients receiving thoracic radiotherapy.

2020 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (7)
HAS2-AS1 Acts as a Molecular Sponge for miR-137 and Promotes the Invasion and Migration of Glioma Cells by Targeting EZH2.

2020 Cell Cycle
Show All
- Source
- Cite
- Save
Citations (2)
YES1 amplification confers trastuzumab–emtansine (T-DM1) resistance in HER2-positive cancer

2020 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Reducing interfacial resistance by Na-SiO2 composite anode for NASICON-based solid-state sodium battery

2019
Show All
- Source
- Cite
- Save
Citations (26)
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models

2019 Cancer Science
Show All
- Source
- Cite
- Save
Citations (18)
SHR‐A1403, a novel c‐Met antibody‐drug conjugate, overcomes AZD9291 resistance in NSCLC cells overexpressing c‐Met

2019 Cancer Science
Show All
- Source
- Cite
- Save
Citations (10)
Pharmacologic Characterization of Fluzoparib, a Novel Poly(ADP‐ribose) polymerase (PARP) Inhibitor Undergoing Clinical Trials

2019 Cancer Science
Show All
- Source
- Cite
- Save
Citations (22)
DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction

2018 Cancer Letters
Show All
- Source
- Cite
- Save
Citations (23)